NCT01950247View on ClinicalTrials.gov

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

PHASE4CompletedINTERVENTIONAL
Enrollment

1,025

Participants

Timeline

Start Date

August 15, 2013

Primary Completion Date

May 20, 2015

Study Completion Date

June 30, 2015

Conditions
Iron Deficiency Anemia (IDA)
Interventions
DRUG

Injectafer

2 doses at 15 mg/kg for a maximum single dose of 750 mg given 7 days apart for a total of up to 1500 mg.

DRUG

SOC

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY